The lancet oncology
-
The lancet oncology · May 2010
Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden.
Cancer is associated with an increased risk of thromboembolic diseases, but data on the association between prostate cancer and thromboembolic diseases are scarce. We investigated the risk of thromboembolic disease in men with prostate cancer who were receiving endocrine treatment, curative treatment, or surveillance. ⋯ Swedish Research Council, Stockholm Cancer Society, and Cancer Research UK.